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Acyl-CoA:cholesterol acyltransferase (ACAT) is a membrane-bound enzyme that produces cho-
lesteryl esters intracellularly. Two ACAT genes (ACAT1 and ACAT2) have been identified. The
expression of ACAT1 is ubiquitous, whereas that of ACAT2 is tissue restricted. Previous research
indicates that ACAT1 may contain seven transmembrane domains (TMDs). To study ACAT2
topology, we inserted two different antigenic tags (hemagglutinin, monoclonal antibody Mab1) at
various hydrophilic regions flanking each of its predicted TMDs, and expressed the recombinant
proteins in mutant Chinese hamster ovary cells lacking endogenous ACAT. Each tagged ACAT2
was expressed in the endoplasmic reticulum as a single undegraded protein band and was at least
partially active enzymatically. We then used cytoimmunofluorescence and protease protection
assays to monitor the sidedness of the hemagglutinin and Mab1 tags along the ER membranes.
The results indicated that ACAT2 contains only two detectable TMDs, located near the N terminal
region. We also show that a conserved serine (S245), a candidate active site residue, is not essential
for ACAT catalysis. Instead, a conserved histidine (H434) present within a hydrophobic peptide
segment, may be essential for ACAT catalysis. H434 may be located at the cytoplasmic side of the
membrane.
INTRODUCTION
Acyl CoA:cholesterol acyltransferase (ACAT) is an intracel-
lular enzyme that uses cholesterol and long-chain fatty acyl
CoA as substrates to produce cholesteryl esters (Chang et al.,
1997). In mammals, two ACAT genes, ACAT1 and ACAT2,
have been discovered (Chang et al., 1993; Anderson et al., 1998;
Cases et al., 1998a; Oelkers et al., 1998; Buhman et al., 2000a;
Rudel et al., 2001; Chang et al., 2001a; Buhman et al., 2001). The
proteins encoded by ACAT1 and ACAT2 share extensive ho-
mology near their C termini but not near their N termini.
Specific antibodies against the N-terminal segments of human
ACAT1 (hACAT1) (Chang et al., 1995) or human ACAT2 (hA-
CAT2) (Chang et al., 2000) were used to study the tissue dis-
tribution of these two isoenzymes. In adult human tissues,
ACAT1 is found in almost all of the cell types and tissues
examined (Lee et al., 1998; Chang et al., 2000; Sakashita et al.,
2000). In contrast, ACAT2 protein is mainly found in the apical
region of the intestinal villi. Low levels of hACAT2 can also be
found in adult human hepatocytes (Chang et al., 2000) and in
activated macrophages (our unpublished data). In mice and
monkeys, the relative tissue distributions of ACAT1 and
ACAT2 are similar but not identical to those found in humans
(Meiner et al., 1997; Buhman et al., 2000b; Lee et al., 2000). Based
on studies in tissue distribution and genetic studies in mice
(Meiner et al., 1996; Buhman et al., 2000b; Spady et al., 2000;
Yagyu et al., 2000), ACAT1 may play a critical role in macro-
phage foam-cell formation, whereas ACAT2 may play a critical
role in the cholesterol absorption process. The exact physiolog-
ical roles of ACAT1 and ACAT2 in various cell types are under
active investigation.
The enzymological properties of hACAT1 and hACAT2
are very similar (Chang et al., 2000). ACAT1 is a homotet-
rameric enzyme (Yu et al., 1999, 2002) and is mainly located
in the endoplasmic reticulum (ER) (Chang et al., 1995;
Sakashita et al., 2000). The subunit composition and the
precise location of ACAT2 are unknown at present. Sparse
information is available regarding the ACAT active site(s): a
conserved serine residue present in ACAT1 (S269), ACAT2
(S245), and the enzyme diacylglycerol acyltransferase 1
(Cases et al., 1998b; Buhman et al., 2001) may be part of the
active site (Cao et al., 1996; Joyce et al., 2000). On the other
Article published online ahead of print. Mol. Biol. Cell 10.1091/
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hand, a superfamily of membrane-bound O-acyltransferases
has been identified (Hofmann, 2000). A histidine (460 in
hACAT1 and 434 in hACAT2) within a long hydrophobic
region is invariant within this family, suggesting that it may
be part of the active site. The suggestions that the conserved
serine and/or the conserved histidine may constitute part of
the ACAT active site were based on computer analysis, not
based on experimental data. Several residues may be in-
volved in binding between ACAT and its substrates (Guo et
al., 2001). Cysteines are not needed for ACAT1 catalysis (Lu
et al., 2002b).
Both ACAT1 and ACAT2 may contain multiple trans-
membrane domains (TMDs). Previously, we created various
hACAT1 constructs tagged at various hydrophilic regions
with a nine amino acid (a.a.) antigenic tag (hemagglutinin
epitope tag, HA) and then expressed the tagged constructs
in mutant Chinese hamster ovary (CHO) cells lacking en-
dogenous ACAT1 (AC29) (Cadigan et al., 1988; Chang et al.,
1993). Indirect immunofluorescence microscopy was used to
determine the topology of the tagged proteins. The results
showed that ACAT1 contains at least seven TMDs (Lin et al.,
1999). In the current study, we used the same strategy, as
well as a protease protection assay to study the hACAT2
topology. The results using different approaches corrobo-
rated one another, enabling us to produce a membrane
topology model for ACAT2. We also performed site-specific
mutagenesis experiments and identified the putative active
site of ACAT. Joyce and colleagues had reported previously
that both ACAT1 and ACAT2 (from monkey) contained five
TMDs (Joyce et al., 2000). The same investigators also pro-
posed that a conserved serine residue (S245 in human
ACAT2) might comprise part of the ACAT active site. Their
results are very different from ours. In the DISCUSSION, we
suggested several clues that might explain the difference in
results seen between our work and the work of Joyce and
colleagues.
MATERIALS AND METHODS
Reagents
Goat anti-rabbit IgG conjugated with Alexa 594 and goat anti-mouse
IgG conjugated with Alexa 488 were from Molecular Probes (Eu-
gene, OR). Trypsin was from Promega (Madison, WI). Soybean
trypsin inhibitor was from Sigma-Aldrich. The anti-ACAT1 mono-
clonal antibody (mAb) Mab1 was from Vancouver Biotech (Vancou-
ver, BC, Canada). The high-titer polyclonal antibodies against the
N-terminal peptide region of hACAT2 (DM54 and DM56) were
described previously (Chang et al., 2000). DM94 are rabbit poly-
clonal antibodies against ACAT2 peptidea.a. 384–433. They were pro-
duced by using the glutathione S-transferase (GST) fusion protein
technology described previously (Chang et al., 1995). As the antigen,
the GST was fused at the N terminus of a peptide comprised of two
repeats of the ACAT2 peptidea.a. 384–433. The DM94 antiserum was
affinity purified using the GST-ACAT2 peptidea.a. 384–433 affinity
column, according to procedure described previously (Chang et al.,
1995). The sources of all other reagents were the same as described
previously (Lin et al., 1999).
Methods
The Construct HisACAT2. The HisACAT2 construct was created
previously (Chang et al., 2000) and contains the HisT7 tag at the N
terminus of hACAT2. The HisT7 tag has 34 amino acids, including
a six-histidine tag, a T7 tag with 11 amino acids, and an enterokinase
cleavage recognition sequence (Invitrogen, Carlsbad, CA).
The ACAT2 Constructs Containing the Hemagglutinin (HA) Tag.
The hemagglutinin epitope tag (HA tag) (Kolodziej and Young,
1991) was inserted into the ACAT2 protein at each of the 10 specific
sites as indicated in Figure 2, A and C.; the specific amino acid after
which the HA tag was inserted has been indicated in the parenthe-
ses of Figure 2C. The various ACAT2-HA constructs were con-
structed by a general procedure that involved ligating two specific
polymerase chain reaction (PCR) fragments of hACAT2 cDNA. The
design of the PCR primers took advantage of the fact that the
protein coding sequence of hACAT2 cDNA did not contain any
EcoR1 sites. The first primer set was designed to produce a PCR
fragment from the N terminus to the specific insertion site. The 5
primer contained the HindIII sequence followed by the ACAT2
N-terminal–specific sequence; the 3 primer contained the ACAT2
sequence before the insertion site, followed by the HA sequence and
the EcoR1 sequence (GAATTC, which encodes the two amino acids
glutamine and phenylalanine). The second primer set was designed
to produce a PCR fragment from the ACAT2 sequence after the
insertion site to the ACAT2 C termini, with an EcoR1 site at the 5
end and a T7 tag sequence and an XbaI sequence at the 3 end. The
5 primer contained the EcoR1 site followed by the ACAT2 sequence
after the insertion site; the 3 primer contained the ACAT2 C-
terminal sequence followed by a T7 tag sequence and an XbaI
sequence. The two resultant PCR fragments were ligated into the
expression vector pcDNA3 between its unique HindIII and XbaI
sites. This procedure resulted in the insertions of the nine amino
acid-HA peptide sequences followed by the two amino acids glu-
tamine and phenylalanine at each indicated site. The identities of
the various pcDNA3-ACAT2-HA constructs were all confirmed by
DNA sequencing.
The ACAT2 Constructs Containing Mab1 Tag. The Mab1 tag, rec-
ognized by the ACAT1 mAb Mab1, is the first 64 amino acids of
hACAT1 (Chang et al., 1993). To produce various ACAT2 constructs
containing the Mab1 tag, two PCR primers were used to generate a
Mab1 fragment with an EcoR1 site at both ends, by using the
hACAT1 cDNA coding region (Chang et al., 1993) as a template.
Then the Mab1 fragment was inserted into the unique EcoR1 site
present in each of theACAT2-HA constructs described above. This
procedure inserted the Mab1 sequence flanked by the two amino
acids glutamine and phenylalanine at each side. The orientation of
the inserted Mab1 fragment was first diagnosed by PCR and then
confirmed by DNA sequencing; those with the correct orientations
were selected for further studies.
The ACAT2 Constructs Containing Various Single Substitution Mu-
tations. Various ACAT2 point mutants were generated by high-
fidelity PCR-based mutagenesis, using Stratagene’s QuikChange
site-directed mutagenesis kit, according to procedures described
previously (Lu et al., 2002b). The identities of the various point
mutations produced were all confirmed by DNA sequencing.
Procedures for Trypsin Protection Assay. Two methods were used.
Method 1 used microsomal vesicles. AC29 cells were grown in
medium A in 25-cm2 flasks to75% confluence. For each flask, 3 g
of individual recombinant ACAT2 cDNA as indicated, and 6 l of
LipofectAMINE were used to transfect the cells according to the
company’s manual. On the 2nd day after transfection, cells were
rinsed twice with phosphate-buffered saline (PBS) and once with
buffer B at 4°C (10 mM HEPES, pH 7.4, 10 mM KCl, 1.5 mM MgCl2,
100 mM NaCl) and were collected by scraping and centrifugation at
4°C. All subsequent operations were kept at 4°C unless stated
otherwise. The cells were homogenized for 20 strokes with a hand-
held stainless-steel tissue grinder (Dura-Grind; Wheaton, Millville,
NJ). Microscopic examinations assured that the cell breakage was
99% complete. The whole cell lysates were transferred into 1.5-ml
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Eppendorf tubes. Each tube contained 50 g of protein. Triton X-100
was added to samples 6 to 10 (at 1% final concentration), but not to
samples 1 to 5. Samples were finger-tapped, incubated for 1 min,
and then a certain amount of trypsin as indicated was added.
Trypsin was prepared as 239 U/ml stock solution in 10 mM HCl,
and stored at 20°C; serial dilutions were freshly made from the
stock and served as working solutions for each experiment. The
samples were incubated at room temperature for 15 min. Adding 2
l/sample of soybean trypsin inhibitor stock solution (at 100 g/l)
inactivated the trypsin digestion. Ten microliters of 5 loading
buffer was added per sample for SDS-PAGE. Method 2 used per-
meabilized cells grown in monolayer. The method was based on the
procedure described by Macri and Adeli, (1997) with minor modi-
fications. AC29 cells were grown in medium A in 12-well plates to
80% confluence. To each well, 0.5 g of individual Mab1-tagged
ACAT2 cDNAs and 6 l of FuGene 6 (Roche Diagnostics, Indianap-
olis, IN) were used to transfect the cells according to the company’s
manual. Twenty-four hours after transfection, cells were rinsed with
PBS with 10 mM dithiothreitol (DTT) and then permeabilized with
either digitonin (0.002%) in buffer D (0.3 M sucrose, 0.1 M KCl, 2.5
mM MgCl2, 20 mM 1,4-piperazinediethanesulfonic acid, 10 mM
DTT, pH 6.8) or with saponin (0.025%) in PBS with 10 mM DTT, 1.0
ml/well, at room temperature for 10 min. Afterwards, 0.5 ml of
buffer D with 10 mM DTT was added to each well. Adding various
amount of trypsin (as indicated in the figure legend) started the
protease digestions. The digestions proceeded at room temperature
for 10 min and were stopped by adding 100 g of trypsin inhibitor
per well. The samples were solubilized with 8 M urea, 0.1 M DTT at
75 l/well. Twenty-five microliters of 5 SDS loading buffer per
well was added, and the samples were analyzed by SDS-PAGE.
Other procedures, including cells and transient transfection ex-
periments, immunoblot analysis, ACAT activity assay in intact cells,
and cytoimmunofluorescence assays have all been described in our
previous work reporting the membrane topology of recombinant
human ACAT1 expressed in AC29 cells (Lin et al., 1999).
RESULTS
Selective Permeabilization of CHO Cells with
Digitonin or Saponin
Our approach is to express various recombinant ACAT2 in
AC29 cells. We then treat the cells with digitonin (an impure
form of the detergent saponin) at low concentration to per-
meabilize the plasma membrane, or with saponin at high
concentration to permeabilize the plasma membrane and the
internal membranes. These treatments allow selective access
of antibodies to the cell cytoplasm only, or to the cell cyto-
plasm and the lumen of the internal membranes. We then
use the method of cytoimmunofluorescence to monitor the
location of the tag inserted at various sites within ACAT2.
To validate the selective membrane permeabilization proce-
dure, we treated AC29 cells with digitonin at low concen-
tration (0.0005%), and performed double cytoimmunofluo-
rescence experiments. The use of double immunofluo-
rescence ensured that the investigators were viewing two
different targets from the same group of cells. We chose
appropriate filters such that the anti-tubulin antibodies were
seen in green and the anti-BiP antibodies were seen in red.
The results showed that tubulin, a cytoplasmic protein
marker, was fully visible, whereas BiP, the lumenal ER
protein marker (Otto and Smith, 1994), was not visible (Fig-
ure 1, top, the first two frames from the left). When we
treated the cells with saponin at high concentration (0.25%),
both tubulin and BiP became fully visible (Figure 1, top,
third and fourth frames from the left). BiP remained within
the ER lumen and displayed a reticular pattern, because the
cells were fixed with paraformaldehyde before they were
permeabilized and stained with the anti-BiP antibodies. We
next transfected AC29 cells with the untagged ACAT2 con-
struct, and performed double immunofluorescence staining
again. We used the high titer polyclonal antibodies (DM56)
against the N-terminal peptide region of hACAT2 (Chang et
al., 2000), and the antibodies against the HA tag as the two
primary antibodies. The DM56 antibodies were seen in red,
and the anti-HA antibodies were seen in green. The results
show that the N-terminal segment of ACAT2 was fully
visible in both digitonin-treated cells and in saponin-treated
cells (Figure 1, bottom, first and the third frames from the
left). Higher magnification of these same cells indicated that
the staining pattern was mainly confined at the nuclear
envelope and at the reticulate network. In addition, double
immunostaining experiments using anti-ACAT2 antibodies
and anti-BiP antibodies showed extensive colocalization of
the two signals, indicating that ACAT2 is mainly located in
the ER membranes (our unpublished data). Because the
ACAT2 construct used was untagged, the stainings using
anti-HA antibodies resulted in no signal in either digitonin-
treated or saponin-treated cells (Figure 1, bottom, second
and fourth frames from the left).
Cytoimmunofluorescence of Various T7-tagged or
HA-tagged ACAT2
Based on the Kyte and Doolittle plot, ACAT2 is a hydropho-
bic protein with multiple TMDs (Figure 2A). It would be
ideal to probe the sidedness of various hydrophilic regions
flanking each putative TMD, by using specific antibodies
that recognize each of these regions. However, after re-
peated attempts, we were only able to produce antibodies
against the N-terminal (DM56 or DM54) and antibodies
Figure 1. Permeabilization of AC29 cells with digitonin at 0.0005%
or with saponin at 0.25%. Cells grown on glass coverslips were fixed
with paraformaldehyde then permeabilized with either digitonin or
with saponin as indicated. The double immunostainings were per-
formed according to methods described in the MATERIALS AND
METHODS. First row, AC29 cells were used; anti-tubulin (viewed
in green) and anti-BiP (viewed in red) were used as the primary
antibodies. Second row, AC29 Cells transiently transfected with
hACAT2 cDNA were used; DM56 (antibodies against the N-terminal
segment of hACAT2; viewed in red) and anti-HA antibodies
(viewed in green) were used as the primary antibodies.
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against antigenic site(s) within a.a. 384–433 (DM94), but
were unable to produce antibodies against any other region
of hACAT2. To circumvent this problem, we inserted the
HA tag (9 a.a.) into various hydrophilic regions flanking the
two sides of each putative TMD. To ensure that the HA tag
insertion does not cause orientation change in the C-termi-
nal, we also inserted the T7 tag (11 amino acids) at the end
of each construct. This insertion allowed us to monitor the
sidedness of the C termini for each tagged proteins (Figure
2C). We used two algorithms, the PhD prediction (Rost et al.,
1995) and the TMpred prediction (Hofmann and Stoffel,
1993), for making TMD predictions (Figure 2B). The sites of
insertion of the tags are shown in Figure 2C. The sequences
of the HA tag and the T7 tag are shown at the bottom of
Figure 2. The various epitope-tagged constructs were ex-
pressed by transient expressions in AC29 cells. Their expres-
sions were monitored by Western blotting with the anti-
hACAT2 antibodies DM56 as the primary antibodies, and by
Figure 2. (A) The hydropathy
plot of ACAT2 according to Kyte
and Doolittle. (B) The transmem-
brane regions of ACAT2, de-
picted as dark boxes as predicted
by the PhD program (T1-T7) or
by the TMpred program (T1-T8).
(C) Diagram demonstrating sites
of insertion to produce various
epitope-tagged human ACAT2
DNA constructs. For each con-
struct, the number of the amino
acid after which the HA tag was
inserted is indicated in the paren-
theses. Each construct listed con-
tained a T7 tag at the C termini.
The peptide sequences of HA and
T7 are given at the bottom.
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using ACAT activity assay in intact cells (Chang et al., 1986).
The results show that all the tagged or the untagged ACAT2
constructs were expressed as a single band with an apparent
molecular mass of 46 kDa on SDS-PAGE (Figure 3A). Deg-
radative fragment(s) from the full-length recombinant
hACAT2s were not detectable (our unpublished data). For
ACAT2s that carried the HA tag and/or the T7 tag, if the
anti-HA antibodies and/or the T7 tag were used as the
primary antibodies for Western analyses, the same results as
shown in Figure 3A were obtained (our unpublished data).
The ACAT activities of various tagged ACAT2 versus those
of the untagged ACAT2 expressed in AC29 cells are shown
in Figure 3B. Based on the protein expression data (Figure
3A) and the activity measurement data (Figure 3B), we
calculated the normalized ACAT activity for each tagged
ACAT2 relative to that of the untagged ACAT2. The results
Figure 3. (A) Analyzing the ex-
pressions of various HA-tagged
ACAT2s by Western blotting.
AC29 cells were transiently trans-
fected with individual HA-
tagged ACAT2 cDNA constructs
as indicated. T7-C is abbreviation
for the construct ACAT2-T7 de-
scribed in Figure 2A. The immu-
noblot was analyzed with the
specific anti-ACAT2 antibodies
DM56 according the method de-
scribed in MATERIALS AND
METHODS. The results were rep-
resentative of two separate exper-
iments. (B) Relative rates of cho-
lesteryl ester biosynthesis in
intact cells expressing various
HA-tagged ACAT2 proteins as
indicated. AC29 cells were tran-
siently transfected with various
indicated HA-tagged ACAT-2
cDNA constructs, then pulsed
with [3H]oleate for 2 h to measure
the rate of cholesteryl ester bio-
synthesis in intact cells by the
method described in MATERI-
ALS AND METHODS. Enzyme
activity assays were performed in
duplicate. Values obtained for
transfectant cells were expressed
as relative activity compared
with AC29 cells, by using the
value obtained in mock-trans-
fected AC29 cells as 1.0. Results
shown were averages of two sep-
arate experiments; sizes of bars
indicated one SE. (C) Normalized
ACAT activity of various HA-
tagged ACAT2s. These values
were calculated by using the in-
dividual values reported in Fig-
ure 3B divided by the individual
intensities of the corresponding
ACAT2 bands shown in Figure
3A. Quantitations of ACAT2
bands were by densitometric
analysis.
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(Figure 3C) show that 1) the insertion of the T7 tag at the C
termini or the insertion of the HA tag at the HA5 site did not
significantly alter ACAT activity; 2) the insertion of the HA
tag at the HA1 or HA3 site caused a significant decrease in
ACAT activity; the activity loss was 30–40%; and 3) the
insertion of the HA tag at HA2, HA2a, HA4, HA6, HA7,
HA7m, or HA8 sites caused a major decrease in ACAT
activity; the activity loss ranged from 65 to 90%.
To determine the sidedness of the individual tag along the
ER membrane, we performed cytoimmunofluorescence. The
double immunostaining procedure was used by adding the
DM56 antibodies and the anti-HA (or the anti-T7) antibodies
simultaneously. The DM56 antibodies were viewed in red,
whereas the anti-HA or the anti-T7 antibodies were viewed
in green. The concentrations of the DM56 and the anti-HA
antibodies (or the anti-T7 antibodies) were used such that
the red color did not overlap significantly in the green filter,
and vice versa. Additional control experiments showed that
if the primary antibodies were deleted from the immuno-
staining procedure, no significant signal was seen when
either the red or the green secondary antibodies was used
alone (our unpublished data). The results of the experiments
are summarized in Figure 4. Each photo is representative of
30 or more randomly chosen fields. The red color shown in
columns 1 and 3 indicated that all of the tagged ACAT2s
were located in the nuclear envelope and the entire reticu-
late network, demonstrating that they were mainly located
in the ER membrane. For all of the tagged ACAT2 examined,
the red color could be readily seen in either digitonin-treated
cells (column 1) or in saponin-treated cells (column 3), indi-
cating that the N-terminal segment of various recombinant
ACAT2 remained to be located in the cytoplasmic side of the
ER membrane. We next used the anti-T7 antibody (viewed
in green) to examine the sidedness of the C termini of
various recombinant ACAT2s, and found that the green
color could also be seen in either digitonin-treated cells, or in
saponin-treated cells. A representative photo, taken from
ACAT2 tagged with T7 at the C termini, is shown in the
bottom row of Figure 4. This result held true for all the
constructs that contained an additional HA tag inserted at
various regions (our unpublished data). Together, the data
indicated that the C-terminal segment of ACAT2 with or
without the additional HA sequence also resided in the
cytoplasmic side of the ER membrane.
When the anti-HA antibodies were used and viewed (in
green) for the ACAT2-HA1 protein, the green color could
only be seen in saponin-treated cells, but not in digitonin-
treated cells (Figure 4, row 1). In contrast, for the ACAT2-
HA2 protein, the green color could be seen in saponin-
treated cells as well as in digitonin-treated cells (Figure 4,
row 2). For all other HA-tagged ACAT2 listed on the left-
hand side of Figure 4 (i.e., ACAT2-HA2a-8), the green color
could be readily seen in either digitonin-treated cells or in
saponin-treated cells (Figure 4, columns 2 and 4).
Cytoimmunofluorescence of Various Mab1-tagged
ACAT2
The results described above suggest that hACAT2 contains
only two detectable TMDs. Based on the prediction algo-
rithms described in Figure 2B, they are probably located
between amino acids 124 and 144, and between 155 and 179.
To test the two TMD model by using a different tag, we
Figure 4. Determining the sidedness along the ER membranes of
the HA tags in ACAT2 by indirect cytoimmunofluorescence. AC29
cells transiently transfected with various HA-tagged ACAT2 con-
structs (indicated at the left) were doubly immunostained with the
ACAT2 N-terminal specific antibodies DM56 providing the red
color, and the anti-HA antibodies providing the green color. The left
two columns show immunostainings after cells were permeabilized
with digitonin; the right two columns show immunostainings after
cells were permeabilized with saponin. In the last row, the double
immunostainings were performed using DM56 providing the red
color and the anti-T7 antibody providing the green color.
S. Lin et al.
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engineered a larger tag (64 amino acid), designated as the
Mab1 tag, at various sites of ACAT2. The sequence of Mab1,
MVGEEKMSLRNRLSKSRENPEEDEDQRNPAKESLETPSN-
GRIDIKQLIAKKIKLTAEAEELKPF, is the same as the first
64 a.a. of hACAT1 (Chang et al., 1993) and contains multiple
lysines and arginines, and is therefore very sensitive to
digestion by trypsin. In addition, this sequence is recognized
by a specific mAb MACAT1 (Chang et al., 1998). In cytoim-
munofluorescence studies, the signal provided by the anti-
body MACAT1 is significantly stronger than that provided
by the anti-HA antibodies (our unpublished data). The no-
menclature and sites of insertion for the Mab1 tags corre-
sponded exactly with those for the HA tags as indicated in
Figure 2.
We expressed various Mab1-tagged ACAT2 constructs in
AC29 cells by transient transfection and monitored their
protein expressions and ACAT activities by the same pro-
cedures as described previously. The results show that all of
the tagged ACAT2 were expressed as a single band with an
apparent molecular mass of 53.7 kDa by SDS-PAGE (Figure
5A). Degradative fragment(s) from the full-length recombi-
nant hACAT2s were not detectable (our unpublished data).
We next compared the ACAT activities of various Mab1-
tagged ACAT2 with that of the untagged ACAT2 (Figure
Figure 5. (A) Analyzing the expres-
sions of various Mab1-tagged ACAT2s
by Western blotting. (B) Relative rates of
cholesteryl ester biosynthesis in intact
cells expressing various Mab1-tagged
ACAT2 proteins as indicated. C. Nor-
malized ACAT activity of various Mab1-
tagged ACAT2s. The experiments were
performed and the results were pre-
sented in the same manner as described
in Figure 3, A–C, but using various
Mab1-tagged ACAT2 constructs (instead
of the HA-tagged ACAT2 constructs).
The sites of insertion for the Mab1 tag,
indicated as Mab1 1-8, or as Mab1-C,
were the same as the sites of insertion for
the HA tag, indicated as HA 1-8 and
shown in Figure 2C.
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5B), and calculated the normalized ACAT activity for each
tagged ACAT2 relative to that of the untagged ACAT2
(Figure 5C). The results show that the insertions of the Mab1
tag caused losses in ACAT activities to various extents. The
tagged ACAT2s remained at least partially enzymatically
active; with percentage of activity remaining ranging be-
tween 30 and 40% for tagged ACAT2s Mab1-1, Mab1-2,
Mab1-7, and Mab1-8; and between 10 and 20% for tagged
ACAT2s Mab1-2a, Mab1-3, Mab1-4, Mab1-5, and Mab1-6.
The tagged ACAT Mab1-C remained 80% as active as the
untagged ACAT2. We next performed double immunostain-
ing experiments, by using the DM54 (which recognizes the
same antigenic site as DM56 and stained the N-terminal of
hACAT2, viewed in red) and the MACAT1 (viewed in
green) simultaneously. The results are summarized in Fig-
ure 6. Each photo is representative of at least 30 randomly
chosen fields. These results indicate that both the N-terminal
and the Mab1 sites located at the C-terminal are accessible in
digitonin-treated cells or in saponin-treated cells. The
Mab1–1 site (inserted before 146th a.a.) is the only site that
was accessible in saponin-treated cells but not in digitonin-
treated cells. The Mab1-2 site (inserted before 195th a.a.) as
well as all other Mab1-tagged ACAT2 listed on the left-hand
side of Figure 6 are all accessible in either digitonin-treated
cells or in saponin-treated cells (Figure 6, columns 2 and 4).
These results corroborated the data by using the HA tag
insertion method and show that the same two TMDs have
been detected.
Protease Protection Assay of Various Mab1-tagged
ACAT2 in Membrane Vesicles
We next tested the two TMD model by using the protease
protection assay. This method is based on the premise that if
the membrane vesicles that contain ACAT2 remain sealed,
only the ACAT2 peptide segments located in the cytoplas-
mic side of the membrane are susceptible to trypsin diges-
tion. We expressed various Mab1-tagged ACAT2 proteins
and then prepared sealed membranes from homogenates of
transfected cells, treated the membranes with or without the
detergent Triton X-100, and performed protease digestions
by using increasing amounts of trypsin. To serve as control,
we monitored the lumenal ER protein marker BiP by using
Western blotting and showed that BiP was partially pro-
tected by membranes against trypsin digestion, but only if
the membranes were not treated with Triton X-100 (Figure
7A, bottom row). This result validated the use of the pro-
tease protection assay in our system. We next monitored the
various Mab1-tagged ACAT2s. The results (summarized in
Figure 7A) showed that only the Mab1-1 site, but not any
other Mab1 sites tested, could be partially membrane-pro-
tected against trypsin digestion, implying that only the
Mab1-1 site of ACAT2 is located in the lumenal side of the
membranes.
As shown in the last lane of Figure 7A, the lumenal ER
protein BiP was partially susceptible to trypsin digestion in
the absence of Triton X-100, suggesting that the microsomal
vesicles isolated in vitro became leaky during trypsin diges-
tion. Regarding the membrane protection against trypsin
digestion, a more reliable procedure was developed by
Macri and Adeli (1997, who showed that in monolayers of
intact cells permeabilized with digitonin, the lumenal pro-
teins residing in the ER membranes remained largely intact
during trypsin digestion. We adopted this procedure and
repeated the trypsin digestion experiment, after transfected
cells were permeabilized with either digitonin (at 0.002%) or
with saponin (at 0.025%). The control experiment (last lane
Figure 6. Determining the sidedness along the ER membranes of
the Mab1 tags in ACAT2 by indirect cytoimmunofluorescence. The
experiments were performed and the results were presented in the
same manner as described in Figure 4, but using various Mab1-
tagged ACAT2 constructs as indicated. The ACAT2 N-terminal
specific antibodies DM54 were used and viewed in red, and the
mAb against Mab1 was used and viewed in green.
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of Figure 7B) showed that, when cells were permeabilized
with the cholesterol binder digitonin at low concentration,
the lumenal ER protein BiP was resistant to trypsin, indicat-
ing that under this condition, the ER membrane remained
sealed during trypsin digestion. Instead, when cells were
permeabilized with saponin (a purified form of digitonin) at
higher concentration, BiP became very susceptible to tryp-
sin, indicating that under the latter condition, ER membrane
becomes leaky, allowing trypsin to gain access to the ER
interior. Additional results of Figure 7B showed that in
digitonin-treated cells, only the Mab1 tag located in site 1
was protected against trypsin digestion. In saponin-treated
cells, all of the Mab1 tags were susceptible to trypsin. Thus,
using two different procedures, the protease protection data
fully corroborated the cytoimmunofluorescence data de-
scribed above. These results suggest that within ACAT2
there are only two detectable TMDs.
Location of the Putative ACAT Active Site along
the ER Membrane
We next sought to identify certain key residue(s) involved in
ACAT catalysis and determine its location along the ER
membrane. A conserved serine (S245 in hACAT2) and a
conserved histidine (H434 in hACAT2) have been impli-
cated as candidate active site residues. To test the function-
ality of S245 and H434, we created four point mutants (A2-
H434A, A2-H434N, A2-S245A, and A2-S245L) by site-
specific mutagenesis, and then expressed these mutants
individually in AC29 cells by transient transfections. The
enzyme activities of these mutants, along with that of the
wild-type ACAT2, were measured in intact cells (Figure 8A),
and normalized by their relative ACAT2 protein expression
levels (Figure 8B). The results (Figure 8C) show that the
A2-S245A mutant and the A2-S245L mutant still contained a
significant amount of residual enzyme activity, whereas the
A2-H434A mutant and the A2-H434N mutant contained
essentially a negligible amount of enzyme activity.
H434 is located within a long hydrophobic peptide seg-
ment of 20 a.a. (Hofmann, 2000). For human ACAT2, this
“signature sequence” corresponds to a.a.420–442. To deter-
mine the location of the peptide that precedes H434, we
created a GST fusion protein, with GST fused at the N
terminus of a peptide comprised of two repeats of the
ACAT2 peptidea.a. 384–433 (sequence shown in Figure 9A).
This fusion protein was expressed in Escherichia coli, purified
to homogeneity, and was used to produce rabbit polyclonal
antibodies DM94. The affinity-purified DM94 specifically
recognizes human HisACAT2 expressed in CHO cells as a
single 51-kDa protein, as shown by Western analysis (Figure
Figure 7 (cont). tection assay by using method 2 described in
MATERIALS AND METHODS. The final concentration of trypsin
(in units per milliliter) present in each sample was as follows: 0 (),
18.6 (), 37.1 (), 74.3 (), 148.5 (), or 297.0 ().
For Figure 7, A and B, Western blotting using the DM10 polyclonal
antibodies monitored the presence of the MAB1 tag in the recom-
binant ACAT2 proteins (53.7 kDa). Western blotting using the anti-
GRP78 monoclonal antibodies (Transduction Laboratories, Lexing-
ton, KY) monitored the presence of the ER protein BiP (78 kDa) in
the ER lumen, as shown in the last lane. The data shown are
representative of three separate experiments.
Figure 7. Trypsin protection assay. (A) Microsomes prepared from
AC29 cells transiently transfected with various Mab1-tagged
ACAT2 constructs as indicated were processed for trypsin protec-
tion assay, by using method 1 described in MATERIALS AND
METHODS. Each membrane preparation was treated with or with-
out Triton X-100 as indicated, and then treated without or with
increasing amounts of trypsin as indicated. The final concentration
of trypsin (in units per milliliter) present in each sample was as
follows: 0 (), 0.25 (), 0.5 (), 1.25 (), or 2.5 (). (B)
Monolayers of AC29 cells transiently transfected with various
Mab1-tagged ACAT2 constructs were permeabilized with digitonin
or with saponin as indicated and were processed for trypsin pro-
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9B). To determine the sidedness of peptidea.a. 384–433 of
hACAT2 in the ER, we performed double cytoimmunofluo-
rescence experiments by adding the DM94 antibodies and
the anti-histidine tag mAb (HisMab) simultaneously to cells
that express HisT7-hACAT2. HisT7-ACAT2 contains a 6 
histidine sequence and the T7 sequence as its N terminus.
Mock-transfected AC29 cells were used as a negative con-
trol. The result shows that, in AC29 cells, the HisTag anti-
body nonspecifically stains the nuclei (Figure 9C, bottom). In
cells expressing HisT7-hACAT2, both the HisTag antibody
and the DM94 gave characteristic ER staining pattern (Fig-
ure 9C, top). The signals were essentially identical whether
the cells were permeabilized with digitonin or with saponin.
This result corroborates the result obtained by using the
ACAT2-HA6 (Figure 4), and demonstrates that the antigen-
ic/hydrophilic region of the peptidea.a. 384–433 resides at the
cytoplasmic side of the ER.
To further probe the environment near the putative active
site H434, we produced a specific HA-tagged ACAT2 con-
struct, designated as ACAT2-HA7m, by inserting the HA tag
before a.a. 432, (which is two residues before H434). We
expressed this construct in AC29 cells by transient transfec-
tions. Activity measurement showed that mutant ACAT2-
HA7m contained 35% of the activity found in wild-type
ACAT2 (Figure 3C, lane 9). We then performed the immu-
noblot analysis and the cytoimmunofluorescence analysis.
The results show that in immunoblot analysis, the HA tag
present in ACAT2-HA7m could be detected (Figure 10B;
lane 2). In contrast, in cytoimmunofluorescence analysis,
irrespective of whether the cells were exposed to the mild
detergent (0.0005% digitonin) or to the stronger detergent
(0.25% saponin), we have consistently failed to detect the
HA signal (Figure 10A; lanes 2 and 4). The control experi-
ment shows that the N-terminal region of ACAT2-7m could
be detected in immunoblot (by DM54; Figure 10B, lane 2),
and by cytoimmunofluorescence (by DM56; Figure 10A,
lanes 1 and 3).
DISCUSSION
The ACAT Active Site, the Proposed ACAT2
Membrane Topology, and the Location of the Active
Histidine
Our current work shows that a conserved histidine (H434 in
hACAT2) may be essential for ACAT catalysis, whereas a
conserved serine (S245 in hACAT2) is not. In results pre-
sented as an abstract, we have tested the functionality of the
conserved serine (S269) and histidine (H460) in hACAT1,
and obtained the same results (Lu et al., 2002a). The results
of the cytoimmunofluorescence assay (Figures 4 and 6) and
the results of the protease protection assay (Figure 7, A and
B) indicate that ACAT2 contains only two detectable TMDs,
located near the N-terminal region. The existence of these
two TMDs has been predicted by the PhD algorithm and the
TMpred algorithm. In contrast, other potential TMDs pre-
dicted by the PhD algorithm or the TMpred algorithm (Fig-
ure 2B) cannot be detected under our assay conditions. The
methods used by us cannot directly detect/view the mem-
brane imbedded region(s). Thus, our current results cannot
rule out the possibility that one or more hydrophobic re-
gions, predicted as potential TMD by various algorithms,
may be partially or entirely embedded in one leaflet of the
lipid bilayer. This type of arrangement has been demon-
strated at the crystal structure level for the membrane bound
enzyme prostaglandin H2 synthase-1 (Picot et al., 1994) and
for a glycerol-conducting channel (Fu et al., 2000). The re-
sults presented in Figure 10 show that the hydrophobic
peptide comprising the putative active H434 is in a shielded
state such that the HA tag inserted nearby is prevented from
reacting with the HA antibodies. This observation led us to
speculate that H434 may be located within the plane of the
membrane lipid bilayer. Similar to this finding, as part of our
work on hACAT1 topology studies, we had produced a
mutant hACAT1-HA7m, by inserting the HA tag before
a.a.459, which is one a.a. before the putative active H460. We
found that the HA tag in hACAT1-HA7m could not be
detected by either cytoimmunofluorescence analysis or by
Figure 8. Enzyme activities of ACAT2 mutants A2-H434A, A2-
H434N, A2-S245A, and A2-S245L. (A) Cholesteryl ester biosynthesis
in intact cells. (B) Immunoblot analysis using anti-ACAT2 antibod-
ies DM54. (C) Normalized ACAT activity of the ACAT2 mutants.
The experiments were conducted and calculated in the same man-
ner as described in Figure 3. Enzyme activity assays were per-
formed in duplicate. Results shown are representative of two sep-
arate experiments.
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immunoblot analysis (results described on p. 23,283 of Lin et
al., 1999). Thus, despite the significant difference in their
membrane topology, the conserved hydrophobic peptide
segment that comprises the putative active histidine in
ACAT1 and ACAT2 may both be partially imbedded within
the lipid bilayer. This arrangement may allow both ACAT1
and ACAT2 to produce cholesteryl esters within the lipid
bilayer and serve their dual roles: to produce cholesteryl
esters that can move to the cytoplasm as lipid droplets
and/or move to the lumen of internal membranes and par-
ticipate in the lipoprotein assembly processes (discussed in
Chang et al., 2001b). To put these considerations together, we
propose a working model for ACAT membrane topology,
shown in Figure 11.
The Discrepancy between Our Current Result and
That of Joyce and Colleagues (Joyce et al., 2000)
Previously, Joyce and colleagues tested the effects of replac-
ing the conserved serine with leucine in ACAT1 and
ACAT2, and concluded that the conserved serine may be
essential for ACAT catalysis. These investigators expressed
their mutant constructs and measured the enzyme activities
in manners similar to ours; however, they did not perform
immunoblot analysis to normalize the difference in the pro-
tein expression levels. As shown in our current work, the
S245L mutation caused the mutant ACAT2 protein to be
expressed at much a lower level than the wild-type ACAT2
(Figure 8). Thus, although the conserved serine may be
important for ACAT protein stability, it is not essential for
ACAT catalysis.
Joyce and colleagues also reported that both monkey
ACAT1 and monkey ACAT2 contained five TMDs (Joyce et
al., 2000). A key difference between our study and their
study is that we relied mainly on the tag insertion approach,
whereas Joyce and colleagues relied mainly on the trunca-
Figure 9. (A) Peptide sequence
of human ACAT2a.a. 384–433 used
to raise rabbit polyclonal anti-
bodies DM94. (B) Specificity of
antibodies DM94 against human
ACAT2 analyzed by Western
blot analysis. The immunoblot
was performed as described in
MATERIALS AND METHODS.
(C) Sidedness of the peptide
a.a.384–433 as probed by indi-
rect cytoimmunofluorescence.
The experiments were performed
according to the method de-
scribed in Figure 4, with the
DM94 antibodies providing the
green color and the antimono-
clonal antibody HisTag provid-
ing the red color. The affinity pu-
rified DM94 was used at 5 g/
ml. The histidine mAb HisTag
(Novagen, Madison, WI) was
used after a 1:1000 dilution from
a 0.2 mg/ml stock.
Figure 10. Detecting the HA tag inserted before a.a.432 of ACAT2 by
cytoimmunofluorescence or by immunoblot. AC29 cells were transfected
with the construct ACAT2-HA7m, with the HA tag inserted before
a.a.432. (A) Indirect cytoimmunofluorescence of transfected cells. The ex-
periments were conducted in the same manner as described in Figure 4.
(B) Immunoblot of transfected cell lysates. Lysates of AC29 cells and cells
that express ACAT2-HA5 (abbreviated as A2-HA5) were used as the
negative and positive controls. The experiments were conducted in the
same manner as described in Figure 3. Results shown are representative of
two separate experiments.
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tion approach. They prepared a series of the target proteins
successively truncated from the C termini after each of the
predicted TMDs; the topology was then determined by mon-
itoring the membrane sidedness of a tag at the C termini of
each fusion protein. These investigators did not report the
percentage of ACAT activity remaining in any of the trun-
cated proteins. We show in our current study that each
tagged ACAT2 is at least partially enzymatically active; we
also show that the C termini of all of these tagged ACAT2
reside in the cytoplasmic side of the ER (Figure 4). Thus,
inserting the HA tag at various flanking sites did not cause
orientation change at the ACAT2 C-terminal. In our unpub-
lished results, we had prepared various hACAT1 constructs
by using the insertion approach and the truncation ap-
proach. Our results showed that using the insertion ap-
proach, the various tagged proteins retained at least partial
enzyme activity, whereas the various truncated proteins had
completely lost their enzyme activities. In principle, both the
insertion approach and the truncation approach run the risk
of altering the membrane topology of the target protein. To
resolve the discrepancy between our results and the results
of Joyce and colleagues, other methods for membrane topol-
ogy determinations that produce minimal structural pertur-
bations of ACAT will be needed.
Regarding the ACAT2 topology, one more major discrep-
ancy existed between our current result and the result of
Joyce and colleagues: our results show that the C termini is
in the cytoplasmic side of the ER, whereas Joyce and col-
leagues showed that the C termini was in the lumen of the
ER. The exact cause of the discrepancy is not known at
present. Below, we offer a certain clue: to determine the
sidedness of the C terminus, both groups used the full-
length ACAT2, and placed certain tags near or at its C
termini. Both groups used AC29 cells as the host for express-
ing the tagged constructs and used cytoimmunofluorescence
to examine the sidedness of the tag after detergent perme-
abilization of cells. We used the double immunostaining
procedure for cytoimmunofluorescence and made sure that
the two signals colocalized when viewed under confocal
microscopy. Joyce and colleagues did not use the double
immunostaining procedure for their studies. It has been our
experience that the transfection procedure (used by both
groups) tends to produce some sick and/or dying cells;
these cells can be as many as 5% of the total cell population.
These cells may not be true transfectants but they tend to
adsorb antibodies nonspecifically. The use of these cells for
data collection should be avoided. The use of double immu-
nofluorescence ensured that the investigators were viewing
the desirable gene product expressed in the transfected cells.
The Difference between ACAT1 and ACAT2 in Terms
of Membrane Topology
The hydropathy plots (Figure 2A; Lin et al., 1999) of ACAT1
and ACAT2 are very similar, though not the same. Although
the seven-TMD model for ACAT1 described previously (Lin
et al., 1999) is very close to prediction by various algorithms,
the two-TMD model for ACAT2 is strikingly different from
prediction. According to the current knowledge (described
in textbooks (Alberts et al., 1994; Lodish et al., 1999), to form
Figure 11. The proposed membrane topology of hACAT2 expressed in CHO cells. The arrows indicated the positions where the HA tags
were inserted. This model proposes that ACAT2 may only contain two detectable TMDs and that the hydrophobic peptide segment peptide
(indicated in yellow color) containing the putative active histidine (H434) may be partially imbedded within the cytoplasmic side of the lipid
bilayer. The extent of insertion of the hydrophobic peptide into the lipid bilayer is unknown. The model is drawn to suggest that additional
hydrophobic region(s) may also be partially imbedded within the lipid bilayer (see text).
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multispanning TM proteins in the ER, multiple topogenic
sequences (i.e., multiple uncleaved signal anchoring se-
quences and/or stop-transfer sequences) are needed. These
sequences interact with the ER transmembrane protein
channel machinery in a reversible manner. The topogenic
sequences are hydrophobic peptides capable of forming
-helices. Additional features that determine the functions
of the topogenic sequences are possible but have not been
generalized. Sequence comparisons show that although sev-
eral highly conserved peptide sequences can be identified in
ACAT1 and ACAT2, most of the TMDs of ACAT1 do not
share high sequence homology with the corresponding do-
mains present in ACAT2. It seems possible that the differ-
ences in the putative TMD sequences may be the underlying
cause for the difference in membrane topology of ACAT1
and ACAT2. It is also possible that similar to ACAT1, mul-
tiple topogenic sequences are present in ACAT2. However,
their membrane insertion/stop transfer functions may be
masked by interaction(s) with other sequence(s) within the
ACAT2 protein, or with nonbilayer lipid, or with other
protein(s).
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